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Abstract
Introduction: Although the number of people receiving antiretroviral therapy (ART) in Indonesia has increased in recent
years, little is known about the specific characteristics affecting adherence in this population. Indonesia is different from
most of its neighbors given that it is a geographically and culturally diverse country, with a large Muslim population. We
aimed to identify the current rate of adherence and explore factors that influence ART adherence.
Methods: Data were collected from ART-prescribed outpatients on an HIV registry at a North Jakarta hospital in 2012. Socio-
demographic and behavioral characteristics were explored as factors associated with adherence using logistics regression
analyses. Chi squared test was used to compare the difference between proportions. Reasons for missing medication were
analyzed descriptively.
Results: Two hundred and sixty-one patients participated, of whom 77% reported ART adherence in the last 3 months. The
level of social support experienced was independently associated with adherence where some social support (p = 0.018)
and good social support (p = 0.039) improved adherence compared to poor social support. Frequently cited reasons for not
taking ART medication included forgetting to take medication (67%), busy with something else (63%) and asleep at
medication time (60%).
Discussion: This study identified that an increase in the level of social support experienced by ART-prescribed patients was
positively associated with adherence. Social support may minimize the impact of stigma among ART prescribed patients.
Based on these findings, if social support is not available, alternative support through community-based organizations is
recommended to maximize treatment success.
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Introduction
Antiretroviral therapy (ART) has dramatically reduced rates of
morbidity and mortality among HIV infected persons worldwide,
transforming the disease from a fatal illness to a manageable
chronic condition [1,2]. While this is a huge achievement, ART
treatment success– defined as sustained virologic suppression and
immunologic recovery, depends fundamentally on patient adher-
ence to treatment [1,3]. Suboptimal adherence can lead to
inadequate viral load suppression, the emergence of resistance,
treatment failure in patients and the potential transmission of drug
resistant virus strains back into the community [2]. WHO
guidelines recommend at least 95% adherence to ART prescribed
medication [4].
Although the importance of ART adherence is widely
recognized, its practice remains a challenge. Very high levels of
adherence are particularly recommended in developing countries
where less robust lines of treatment, such as non-nucleoside
reverse transcriptase inhibitors (NNRTI), are commonly used [5].
However socio-demographic, cultural, economic and health care
systems related factors are proven barriers to successful adherence.
Indonesian studies have shown that stigma and discrimination can
further impede adherence by forcing HIV-infected patients to
keep their status a secret for fear of being outcaste by their
community and bringing shame on the family [6,7].
In a recent global systematic review of factors causing ART
interruption the most frequently reported reasons were related to
drug toxicity and side effects, with developing countries addition-
ally referencing the cost of ART treatment and frequent pharmacy
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stock-outs as further barriers [8]. Another recent systematic review
of studies across Asia showed that poor adherence was largely due
to the financial burden of ART treatment, with travel and
diagnostic costs further impeding access [9]. A Nepalese study
found that non-disclosure of HIV status, alcohol use and being
female as major prohibiting factors [10] while an Indian study
showed that a lack of social support and in particular a lack of
reminders from family to take medication were negatively
associated with adherence [11]. To date no studies have been
published on risk factors for ART interruption in Indonesia.
Although the number of people receiving ART in Indonesia has
increased in recent years, from 2,381 in 2006 to 24,410 in 2011
[12,13], little is known about the specific characteristics affecting
levels of adherence in this population. Indonesia is different from
most of its neighbors given that it is a geographically and culturally
diverse country, with a large Muslim population of which many
fast during Ramadan every year. The impact of the religious and
cultural diversity on ART adherence is not well established, but
warrants investigation.
Sulianti Saroso Infectious Disease Hospital is one of the national
referral hospitals for HIV-AIDS, located in North Jakarta
(Figure 1). The hospital currently serves more than 1,300 ART
prescribed patients. The hospital also provides stocks of ART and
training to primary health clinics that administer ART to patients
on their registries. At this hospital, nurses have reported poor
monthly re-attendance by ART prescribed patients to collect their
ART medication from the pharmacy service. This is used by the
hospital as a proxy to gauge adherence rates as outpatients are
given only one-month supply of medication at each visit. This,
combined with frequent self-reporting of poor adherence by
patients on ART for more than one year, was the rationale for
undertaking this study.
This study draws on this hospital-based sample of ART
prescribed patients at Sulianti Saroso Infectious Disease Hospital
in North Jakarta. We aimed to identify the current rate of
adherence and explore factors that influence adherence in this
setting.
Methods
Ethics
Ethics approval for this study was obtained from University of
Indonesia with the approval number 486/PT02.FK/ETIK/2012.
Written consent was also obtained from respondents at time of
interview.
Study design and setting
A cross-sectional study was conducted between August and
November 2012 and included a quantitative survey of ART
prescribed patients from Sulianti Saroso Infectious Disease
Hospital. This hospital was selected because of its long experience
in HIV case management, the presence of an HIV specialist team
as well as an in-house research unit, and because it is one of the
most prominent ART administering sites in Jakarta.
Data collection
Respondents were taken from the hospital HIV outpatient
registry and considered eligible if $ 18 years old and on ART for
at least 6 months. Nurses explained the objectives of the study to
patients collecting their ART medication from the hospital and
asked for their consent to participate. Of respondents who agreed
to participate, they were then asked to complete a questionnaire in
a private room with a nurse present. This questionnaire assessed
socio-demographic characteristics, access to health facilities,
knowledge of HIV and ART, and adherence in the last four days
and last three months. Patients were considered adherent based on
two measures- if they self-reported taking $ 95% of ART
medication in a 4-day (missing $ 1 dose of ART medication
within this time period was determined as non-adherent) and a 3-
month (missing $ 3 doses of ART medication within this time
period was determined as non-adherent) recall period immediately
prior to the interview date [10,14].
Respondents were asked about social support and how they
perceive themselves (personal stigma) and how they think others
perceive them (external stigma) due to their HIV status. The
Interpersonal Support Evaluation List (ISEL) - a 40-item Likert
scale with responses from 0 ‘‘definitely false’’ to 3 ‘‘definitely true’’-
was adapted to exclude one question that was deemed culturally
inappropriate and used to determine the level of social support
experienced by respondents [15]. Negative items were reverse
coded and scores ranged from 0 to 117 with higher scores
suggesting greater perceived social support. The Perceived Social
Stigma (PSS) tool - also a 40-item Likert scale with responses from
1 ‘‘strongly disagree’’ to 4 ‘‘strongly agree’’– was adapted and all
40 questions were used to determine the level of personal and
external stigma [15]. Total scores ranged from 0 to 160, with
higher scores indicating more stigma.
Analysis
To assess factors associated with adherence, the dependent
variable was ‘adherence to ART’ using a 3-month recall period
and independent variables included socio-demographic and
cultural variables, access to health facilities, knowledge of ART,
personal and external stigma and social support. See Study
Dataset S1 for the dataset used in this study.
The ISEL tool does not prescribe cut offs for levels of social
support experienced and therefore for our analyses scores were
categorized into three groups. The 3 groups for social support
were ‘‘poor’’ = 60 or less, ‘‘some’’ = 61–70 and ‘‘good’’ = 71 or
more. For the PSS scale, questions were divided into two groups
for analysis- those that focused on personal stigma and those that
focused on external stigma. For the personal stigma assessment
scores ranged from 0 to 95 (with scores between 0 and 46
indicating less stigma) and for the external stigma assessment
scores ranged from 0 to 153 (with scores between 0 and 34
indicating less stigma) [15].
Chi squared test was used to compare the difference between
proportions. Logistic regression analysis was performed to
determine variables associated with adherence. The dependent
variable was coded as binary (0 = adherent and 1= non-adherent).
Univariable analyses were initially conducted and all variables
with p-value #0.1 were entered into a multiple logistic regression
model. Backward stepwise selection was used to determine
variables independently associated with adherence at p,0.05
level. All analyses were conducted using Stata V.11 [16].
Results
Quantitative results
In total 276 ART prescribed patients were approached and 261
agreed to participate (95%, Table 1); 74% were male and the
mean age was 33.4 years (range 20 to 61). The majority (60%) of
respondents had completed secondary school, 54% were married
and 41% were unemployed. Of all respondents, 29% reported
ever injecting drugs. The majority (73%) were Muslim, of whom
51% stated they fast during Ramadan every year, 45% travel more
than 10 km to collect ART medication and the median time since
HIV diagnosis was 50.1 months (IQR 29.3–65.8). The median
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duration on ART was 45.7 months (IQR 25.7–60.7). The median
duration since last CD4 count test was 10.2 months (IQR 5.2–
19.8) with 44% of respondents reporting that their last CD4 count
test was over 1 year ago. Of patients, 13% reported ever having an
opportunistic infection since their HIV diagnosis.
Most (89%) respondents reported ART adherence in the last 4
days with fewer reporting adherence in the last 3 months (77%;
p,0.001). The majority also reported experiencing stigma because
of their HIV status, with 84% reporting personal stigma and 77%
reporting external stigma. The majority (52%) reported good
social support while 38% and 10% reported some and poor social
support respectively.
Factors associated with adherence to ART
Four variables had P values #0.1 on univariable analyses
(Table 2): marital status, education, fasting and social support.
Age, sex, number of children, number of people in household,
hours worked, injecting drug use, religion, total monthly
household expenditure and distance to medication were not
associated with adherence (data not shown).
Multivariable analysis (Table 2) showed that the level of social
support experienced by respondents affected adherence; greater
levels of social support significantly improved adherence. Using
poor social support as the reference group, some social support
(p = 0.018) and good social support (p = 0.039) both significantly
improved adherence levels.
Of the 61 respondents that reported non-adherence in the last 3
months, 57 identified one or more reasons for non-adherence
(Table 3). Frequently cited reasons include forgetting to take
medication (67%), busy with something else (63%), asleep at
medication time (60%) and ran out of medication (44%). Other
common barriers included medication only being available far
from house (37%), not wanting others to know they were taking
HIV medication (35%) and too many pills to swallow (33%).
Discussion
This study described the self-reported adherence rate in the 3
months prior to the study among ART prescribed patients
attending a large infectious disease referral hospital in North
Jakarta in 2012. The rate of adherence in our sample (77%) is
comparable to other Asian studies using a self-reporting measure
for adherence [11,17,18]. This rate is also higher than adherence
rates reported in some North-American based studies [19].
Possible reasons for these higher rates of adherence are that we
relied on self-reporting which can overestimate adherence [20]
and that we recruited patients who were actively engaging with a
large referral hospital in a metropolitan area.
Figure 1. Location of Sulianti Saroso Infectious Disease Hospital in North Jakarta, Indonesia.
doi:10.1371/journal.pone.0107543.g001
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Table 1. Socio-demographic characteristics of ART prescribed patients at Sulianti Saroso Infectious Disease Hospital, Jakarta,
N = 261.
Variable N %
Sex
Male 193 73.9
Female 68 26.1
Age
30 and under 91 34.9
31 to 40 141 54.0
41 and over 29 11.1
Marital status
Not married 82 31.4
Married 142 54.4
Divorced/widowed 27 14.2
Children
Yes 145 55.6
No 116 44.4
Education
Primary 40 15.3
Secondary 157 60.2
Tertiary 64 24.5
Hours worked
Full time 109 41.8
Part time 44 16.9
Not working 108 41.4
History of injecting drug use
Yes 76 29.1
Religion
Muslim 191 73.2
Catholic 47 18.0
Other 23 8.8
Ramadan fasting (N=191 Muslims)
Yes 98 51.3
No 93 48.7
HIV diagnosis (months) Median (IQR) 50.1 (29.3–65.8)
ART initiated (months) median (IQR) 45.7 (25.7–60.7)
Last CD4 count (months) median (IQR) 10.3 (5.2–19.8)
Co-infection 35 13.4
Yes
Distance to medication
10 km or less 143 54.8
Over 10 km 118 45.2
Self-reported adherence
Last 4 days 233 89.3
Last 3 months 200 76.6
Stigma
Experienced personal stigma 218 83.5
Experienced external stigma 202 77.4
Social support
Poor (60 or less) 26 10.0
Some (61–70) 98 37.6
Good (71 or more) 137 52.5
doi:10.1371/journal.pone.0107543.t001
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Our study found that greater social support, as assessed by the
Interpersonal Support Evaluation List scale, was significantly
associated with adherence, which is consistent with other studies
[11,21–23]. This suggests that family and friends play an
important role in supporting ART prescribed patients, potentially
by reminding them to take their medication, assisting with the
collection of ongoing ART medication, increasing their sense of
connectedness to others, reducing isolation and providing an
incentive outside of themselves to adhere to treatment. Further-
more, social support may minimize the impact of stigma among
ART prescribed patients. Although many respondents in our study
Table 2. Relationship between patient characteristics and three month drug adherence, N = 261.
Adherence (%) Univariable Mulitvariate
Variable Not adherent Adherent OR (95% CI)a P-value OR (95% CI)a P-value
Gender
Male 44 (22.8) 149 (77.2)
Female 17 (25) 51 (75) 1.129 (0.59–2.15) 0.712
Age
30 and under 22 (24.2) 69 (75.8)
31 to 40 32 (22.7) 109 (77.3) 0.921 (0.49–1.71) 0.794
41 and over 7 (24.1) 22 (75.9) 0.998 (0.38–2.65) 0.997
Marital status
Not married 18 (21.9) 64 (78.1)
Married 32 (22.5) 110 (77.5) 3.048 (0.07–0.91) 0.071
Divorced/widowed 11 (29.7) 26 (70.3) 0.936 (0.91–0.31) 0.907
Children
No 35 (24.1) 110 (75.9)
Yes 26 (22.4) 90 (77.6) 1.482 (0.63–3.55)
Education
Primary 13 (32.5) 27 (67.5)
Secondary 29 (18.5) 128 (81.5) 0.471 (0.22–1.02) 0.039
Tertiary 19 (29.7) 45 (70.3) 0.877 (0.37–2.10) 0.545
Work
Not working 31 (20.3) 122 (79.7)
Working 30 (27.8) 78 (72.2) 0.661 (0.37–1.18) 0.159
Religion
Buddhist 3 (27.3) 8 (72.7)
Catholic 8 (13.6) 51 (86.4) 0.418 (0.09–1.92) 0.262
Muslim 50 (26.2) 141 (73.8) 0.946 (0.24–3.70) 0.936
Fasting
No 32 (19.6) 131 (80.4)
Yes 29 (29.6) 69 (70.4) 1.721 (0.96–3.08) 0.067
Distance to medication
10 km or less 35 (24.5) 108 (75.4)
Over 10 km 26 (22.0) 92 (78.0) 0.872 (0.49–1.56) 0.643
Total monthly household expenditureb
1 000 000 or less 11 (19.3) 46 (80.7)
Between 1 and 2 million 23 (28.6) 57 (71.4) 1.687 (0.75–3.82) 0.209
More than 2 million 22 (27.2) 59 (71.8) 1.559 (0.69–3.54) 0.288
Level of social support received from
others
Poor (60 or less) 11 (42.3) 15 (57.7)
Some (61–70) 19 (19.4) 79 (80.6) 0.328 (0.130–0.827) 0.018 0.328 (0.130–0.827) 0.018
Good (71 or more) 31 (22.6) 106 (77.4) 0.399 (0.166–0.957) 0.039 0.399 (0.166–0.957) 0.039
aOR odds ratio; CI confidence interval.
bData missing (total monthly expenditure n= 218).
doi:10.1371/journal.pone.0107543.t002
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reported experiencing personal or external stigma, this did not
impact their ART adherence.
Based on these findings, if social support is not available,
alternative support through community-based organizations
should be provided where possible to improve the social networks
of ART prescribed patients and maximize treatment success. At
Sulianti Saroso Infectious Disease Hospital, there are psychosocial
counsellors and HIV infected community groups that provide
social to HIV patients. This structure can be used to address social
support issues once non-adherent ART prescribed patients are
identified. Qualitative studies of the relationship between ART
adherence, social support and stigma are recommended in the
future.
Unlike previous studies that found low educational attainment
to be a predictor for non-adherence, educational attainment was
not independently associated with ART adherence in our study.
This is a surprising finding as higher levels of education and
literacy likely facilitate better communication between the patient
and the health worker, increase retention of information provided
by the health worker and therefore ensure a greater understanding
of how to take ART medication by the patient. Literacy is also
empowering, and a lack thereof may result in a reluctance from
patients to ask others for help [24]. Further research is needed to
explore the relationship between education levels and drug
adherence in this hospital setting.
The key reasons for not taking ART medication given by
patients were forgetfulness, being busy with something else,
sleeping when meant to be taking medication and running out
of medication. While behavioral reasons are difficult to address
programmatically, increasing awareness of the importance of
taking medication as prescribed is essential and must be
emphasized in pre-treatment counseling and all subsequent
engagements with health services providing ART medication.
Patient recall to the clinic to collect new batches of drugs should be
actively encouraged.
Despite sickness being a recognized exemption from fasting in
Islam, over half of ART prescribed patients in our sample who
identified as being Muslim stated they fast every year during
Ramadan. Fasting did not have a significant effect on adherence
rates which is consistent with other literature from Sub-Saharan
Africa [25]. This study showed that patients altered their typical
daily ART consumption behaviors by advancing morning and
delaying evening doses during Ramadan [25]. Another study
looking at the impact of fasting on patients with chronic asthma
also found that fasting did not affect adherence to treatment but
rather affected the times at which medication was used by patients
[26]. Patients in our study may have rearranged their medication
consumption times. Where appropriate, counseling for ART
treatment needs to include discussion on fasting. If patients plan to
fast during Ramadan this needs to be carefully monitored to
ensure optimal adherence is maintained. The impact of resched-
uling drug therapy on adherence has also not been explored and is
recommended in future studies.
An additional finding from this study was that many ART
prescribed patients do not receive CD4 count tests annually (44%),
although this is recommended in WHO guidelines [27]. Future
ART programs need to scale up annual CD4 count testing in their
ART prescribed patients to monitor their treatment, and if this is
too costly, alternative measures for monitoring viral load need to
be utilized.
The main strength to our study is that it is the first to examine
adherence to ART in Indonesia. Our study also had a high
response rate- fifteen patients (5%) who were asked to participate
refused to do so. However the study does have some limitations.
Due to financial constraints, adherence was based on self-reporting
as opposed to more objective tools such as electronic pill caps or
pill counts. While there are concerns that self-reporting reflects
only short-term or average adherence and may often overestimate
adherence [28], previous studies have determined this to be an
appropriate, robust indicator of adherence.
Another limitation to this study is that only patients who
attended the hospital were included. Those who did not attend or
had others collecting their medication on their behalf were not
interviewed and may differ in terms of their adherence and the
severity of their disease. This may influence the generalizability of
the results. Also given that the focus of this study was to explore
adherence, our selection criteria included treatment with ART for
a minimum of 6 months, and therefore the proportion of patients
Table 3. Reasons provided by non-adherent respondents for missing medication, N = 57.
Variable* N %
Forgot 38 66.7
Busy with something else 36 63.2
Asleep at time of taking medication 34 59.6
Run out of medication 25 43.9
Far from house 21 36.8
Not wanting others to know taking HIV medication 20 35.1
Too many pills to swallow 19 33.3
Feeling sick or unwell 18 31.6
Feeling depressed or hopeless 18 31.6
Have trouble swallowing medication 14 24.6
Want to avoid the side effects 13 22.8
Already feel healthy 12 21.1
There is a change in routine 11 19.3
Felt the drug was toxic 10 17.5
*Multiple answers allowed.
doi:10.1371/journal.pone.0107543.t003
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with early abandonment was not explored in the study. This study
is also a cross-sectional analysis, measuring adherence at a single
time point. However adherence is a process that inevitably varies
over time, meaning that multiple interviews with patients may
have provided greater insight into adherence behavior. Longitu-
dinal studies engaging with a variety of HIV patients in
combination with a variety of tools for measuring adherence
including grading patient adherence or exploring psychological
factors such as depression are recommended in the future, to
understand adherence more comprehensively.
Lastly, this study sample is based on patients actively engaging
with a hospital in a metropolitan area in the wealthiest province of
Indonesia and therefore these findings may not be generalizable to
other parts of the country, and in particular to more remote and
disadvantaged locations. Further studies are needed in other areas
of Indonesia to gain a more accurate understanding of the levels of
adherence and how they vary based on geographical, cultural,
religious and ethnic differences.
Conclusion
This study has identified that an increase in the level of social
support experienced by ART prescribed patients was positively
associated with adherence. Forgetting to take medication, busy
during time of taking medication and running out of medication
were common reasons for not adhering to treatment. Given that
social factors and behavioral patterns influence adherence,
interventions need to target these issues in order to maximize
treatment success. The focus needs to be on providing opportu-
nities for social networking among ART prescribed patients when
needed, eliminating barriers to accessing treatment, monitoring
the progress of therapy as well as CD4 count regularly, increasing
patient’s awareness of ART treatment and improving medical
record keeping of patients. Policy makers must work towards
policies that encourage patients to achieve optimal adherence
levels. Further studies are also recommended in other settings of
Indonesia given that geographical, social, cultural, religious and
health service access factors differ significantly across the country.
Qualitative studies reviewing the relationship between ART
adherence, social support and stigma are also recommended.
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